Esophagogastric Junction Adenocarcinoma Clinical Trials in Nanjing, Jiangsu

Efficacy and Safety of Anti-PD-1, Thymalfasin, and SOX in Neoadjuvant Treatment of cStage III Gastric/Gastroesophageal Junction Adenocarcinoma